Long-term benefits of inhaled tobramycin in children with cystic fibrosis: First clinical observations from Poland

Respiration

Volumn 75, Issue 2, 2008, Pages 178-181

  Stelmach, Iwona ^a,b   Korzeniewska, Aleksandra ^a   Stelmach, Włodzimierz ^a  

^a N Copernicus Hospital   (Poland)

^b N Copernicus Hospital ^*  (Poland)

Author keywords

Cystic fibrosis; Inhaled drug therapy; Nutritional status; Pulmonary function tests; X ray

Indexed keywords

AZITHROMYCIN; DORNASE ALFA; TOBRAMYCIN;

ADOLESCENT; ADULT; AIRWAY RESISTANCE; ARTICLE; BACTERIAL INFECTION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LUNG FUNCTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; THORAX RADIOGRAPHY; TREATMENT DURATION;

ADMINISTRATION, INHALATION; ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; POLAND; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; TOBRAMYCIN;

EID: 40549095341     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101725     Document Type: Article

References (21)